Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Caffeine Citrate

Aliases
Caffeine
Name
caffeine citrate
INN Name
CAFFEINE CITRATE
FDA Approved
Yes

4 clinical trials

7 organizations

5 indications

4 documents

Indication
Preterm
Indication
Apnea of Prematurity
Indication
Caffeine
Indication
Respiratory Distress Syndrome
Indication
Depressed Glasgow Coma Scale (GCS)
Clinical trial
Changes in Diaphragmatic Activity Before and After Caffeine Citrate Administration and Discontinuation
Status: Completed, Estimated PCD: 2023-10-18
Clinical trial
Treatment With Caffeine of Very Preterm Infant in the Delivery Room: the CAFROOM Feasibility Study
Status: Completed, Estimated PCD: 2021-06-30
Clinical trial
Randomized Controlled Trial of Home Therapy With Caffeine Citrate in Moderately Preterm Infants With Apnea of Prematurity
Status: Active (not recruiting), Estimated PCD: 2023-03-01
Clinical trial
CaffeinICU Study - A Multi-centre Pilot Study to Examine the Safety and Feasibility of Oral Caffeine in Critically Ill Adult Patients With Low Glasgow Coma Scale Score.
Status: , Estimated PCD: 2025-12-31
Document
DailyMed Label: caffeine citrate
Organization
Exela Pharma Sciences, LLC
Organization
Fresenius Kabi USA, LLC
Organization
Sun Pharmaceutical Industries, Inc.
Organization
Hikma Pharmaceuticals USA Inc.
Organization
AuroMedics Pharma LLC
Document
DailyMed Label: CAFFEINE CITRATE
Organization
Armas Pharmaceuticals Inc.
Document
DailyMed Label: Caffeine Citrate Oral Solution
Document
DailyMed Label: CAFCIT
Organization
Sun Pharmaceutical Industries Ltd